Immunoassay reagents, and hospitals and laboratories segments to contribute massively towards growth in the market
Growth in geriatric population and higher incidence of chronic diseases to propel market onto a high growth trajectory
ALBANY, New York, March 18, 2020 /PRNewswire/ -- The global life science reagents market is expected to grow at a rate of approximately 8%, compounded annually, from 2019 to 2027. The market worth in the year 2018 stood at about USD 37 bn. and is set to reach the mark of USD 73 bn. by the end of the forecast period. The growth that is projected for the market over the stated period is a result of the reagents' critical role in pharmaceuticals and health-related solutions.
As per Transparency Market Research, "Global Life Science Reagents Market Growth is attributable to a rapidly ageing population and an increase in incidence of chronic diseases, noted worldwide. Additionally, the technological advancements that are marking the market landscape are also propelling it on a high growth trajectory."
Key Findings of Global Life Science Reagents Market Study:
Product-wise, immunoassay reagents segment would be at the forefront of growth that is set to be witnessed in the market
High preference in hospitals and path labs to drive growth in the immunoassay reagents segment
Hospitals and diagnostic laboratories to dominate the end-user segment of the global life science reagents market
Growth in the hospitals and laboratories segment would be owed to an increase in chronic diseases and a resultant need for diagnosis
Region-wise, North America would be a dominant regional market over the forecast period
Regional Analysis of Global Life Science Reagents Market:
North America to dominate the global life science reagent market over the forecast period owing to extensive research and development of activities marking the landscape
Expansion of laboratory tests portfolio also contributing immensely to the growth of North American region
Asia Pacific region to chart a high compound annual growth rate owing to a massive patient pool and improvement in infrastructure (healthcare)
India and China to be significant contributors of growth in the regional market
Analyze life science reagents market growth in 30+ countries including US, Canada, Germany, United Kingdom, France, Italy, Russia, Poland, Benelux, Nordic, China, Japan, India, and South Korea. Request a sample of the study
Competitive Landscape of Global Life Science Reagents Market
Prominent players operating in the global life science reagents market are Hoffmann-La Roche AG, Danaher Corporation, Abbott, Siemens Healthineers, DiaSorin S.p.A, Sysmex Corporation, bioMerieux SA, Thermo Fisher Scientific, Inc., BD, Merck KGaA, Agilent Technologies, Inc., and Waters Corporation
In order to claim a large section of overall market growth, players are deploying a number of growth strategies. Product development is a major strategy. Others include mergers and acquisitions and strengthening of distributional channels.
The global life science reagents market has been segmented as follows:
Global Life Science Reagents Market by Product
Molecular Diagnostic Reagents
Clinical Chemistry Reagents
Flow Cytometry Reagents
Cell & Tissue Culture Reagents
Hematology & Hemostasis Reagents
Global Life Science Reagents Market by End User
Hospitals & Diagnostics Laboratories
Commercial & Contract Research Manufacturers
Academic & Research Institutes
Global Life Science Reagents Market by Region
Rest of the Europe
Australia & New Zealand
Rest of Asia Pacific
Rest of Latin America
Middle East & Africa
Rest of Middle East & Africa
Explore Transparency Market Research's award-winning coverage of the global Healthcare industry:
Biopharmaceuticals Market - The demand for biopharmaceuticals products have grown considerably in the past few years, as biopharmaceuticals are structurally similar to human body components. This factor helps in treating cancer, diabetes, psoriaisis, rheumatoid arthritis, and other in a very effective manner.
Immunoassay Market - The global market for immunoassay stood at US$ 16.54 Bn in 2017, is anticipated to reach a value of US$ 28.61 Bn by the end of 2026. The market is expected to register a strong 6.20% CAGR between 2018 and 2026.
In Vitro Diagnostics Market - In 2016, the global market for in vitro diagnostics was worth US$55000 mn and is projected to reach a value of US$89862.2 mn by the end of 2025. The market is projected to register a healthy 5.60% CAGR between 2017 and 2025, states a new research study by Transparency Market Research.
Gain access to Market Ngage, an AI-powered, real-time business intelligence that goes beyond the archaic research solutions to solve the complex strategy challenges that organizations face today. With over 15,000+ global and country-wise reports across 50,000+ application areas, Market Ngage is your tool for research on-the-go. From tracking new investment avenues to keeping a track of your competitor's moves, Market Ngage provides you with all the essential information to up your strategic game. Power your business with Market Ngage's actionable insights and remove the guesswork in making colossal decisions.
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.